ERBB2 and neoplasm: In detail, 5 patients with luminal B HER2− primary tumors had triple negative recurrences, 3 patients with triple negative primary tumor relapsed with luminal HER2− tumor, and 2 patients with luminal HER2+ primary disease had a luminal HER2− recurrence.